E. Zwanziger

发表

Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug‐disease modelling for dosing regimen optimization

L. Gibiansky, K. Patel, Patrick F. Smith, 2020, British journal of clinical pharmacology.

706 POSTER A phase I dose escalation pharmacokinetic (PK) and pharmacodynamic (PD) study of weekly and twice weekly erlotinib in advanced stage solid malignancies

K. Gelmon, S. Chia, C. Kollmannsberger, 2007 .

Determination of linear alkylbenzenesulfonates in communal wastewater by means of solid phase microextraction coupled with API-MS and HPLC-FLD

U. Ceglarek, W. Engewald, A. Schreiber, 1999 .

Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers

D. Bentley, E. Winter, A. Geretti, 2020, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic Interaction Study of Ritonavir-Boosted Saquinavir in Combination with Rifabutin in Healthy Subjects

Xiaoping Zhang, L. Rowell, E. Zwanziger, 2010, Antimicrobial Agents and Chemotherapy.

Stabilization of clinical samples collected for quantitative bioanalysis--a reflection from the European Bioanalysis Forum.

Peter van Amsterdam, Martijn Hilhorst, Katja Heinig, 2015, Bioanalysis.

Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and Infants

L. Gibiansky, N. Parrott, S. Sturm, 2020, Clinical pharmacology and therapeutics.

Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission

A. Hurt, Jie Zhou, T. Uehara, 2020, PLoS pathogens.

Effect of Saquinavir‐Ritonavir on Cytochrome P450 3A4 Activity in Healthy Volunteers Using Midazolam as a Probe

C. Hofmann, E. Zwanziger, C. Schmitt, 2009, Pharmacotherapy.

Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir

Xiaoping Zhang, E. Zwanziger, C. Schmitt, 2008, Antimicrobial Agents and Chemotherapy.

Dosing regimen optimisation for oseltamivir in immunocompromised paediatric patients with influenza: Extrapolation of efficacy

Timothy D. Knab, L. Gibiansky, J. Hernández-Sánchez, 2021, British journal of clinical pharmacology.

What are the challenges of stability investigations and sample stabilization in regulated bioanalysis?

K. Heinig, D. Zimmer, E. Zwanziger, 2013, Bioanalysis.

What are the challenges of stability investigations and sample stabilization in regulated bioana lysis? " …stability experiments cannot be continued beyond practicability/feasibility due to cost-benefit issues, rather, one should conduct proper risk assessment..."

F Hoffmann-La, Katja Heinig, Elke Zwanziger, 2013 .

Determination of dalcetrapib by liquid chromatography-tandem mass spectrometry.

K. Heinig, M. Zell, O. Kuhlmann, 2012, Journal of pharmaceutical and biomedical analysis.

In vitro and clinical investigations to determine the drug-drug interaction potential of entrectinib, a small molecule inhibitor of neurotrophic tyrosine receptor kinase (NTRK)

S. Fowler, F. Mercier, Kenichi Umehara, 2021, Investigational New Drugs.

Bio-analytical aspects and challenges in supporting pediatric drug development.

K. Heinig, D. Fraier, E. Zwanziger, 2020, Bioanalysis.